Literature DB >> 31056732

Completeness of total mesorectum excision of laparoscopic versus robotic surgery: a review with a meta-analysis.

Marco Milone1, Michele Manigrasso2, Nunzio Velotti2, Stefania Torino3, Antonietta Vozza3, Giovanni Sarnelli2, Giovanni Aprea2, Francesco Maione2, Nicola Gennarelli2, Mario Musella2, Giovanni Domenico De Palma2.   

Abstract

BACKGROUND: TME has revolutionized the surgical management of rectal cancer, and since the introduction of robotic TME (RTME), many reports have shown the feasibility and the safety of this approach. However, concerns persist regarding the advantages of robotic in surgery for the completeness of TME. The aim of this review is to compare robotic versus laparoscopic total mesorectal excision (TME) in rectal cancer, focusing on the completeness of TME.
METHODS: A systematic search was performed in the electronic databases for all available studies comparing RTME versus conventional laparoscopic LTME with declared grade of mesorectum excision. Data regarding sample size, clinical and demographic characteristics, number of complete, nearly complete, and incomplete TME were extracted. Primary outcome was the number of complete TME in robotic and laparoscopic procedures. Secondary outcomes were the numbers of nearly complete and incomplete TME in robotic and laparoscopic rectal resections.
RESULTS: Twelve articles were included in the final analysis. Complete TME was reported by all authors, involving 1510 procedures, showing a significant difference in favor of robotic surgery (OR = 1.83, 95% CI 1.08-3.10, p = 0.03). Nearly complete and incomplete TME showed no significant difference between the procedures. Meta-regression analysis showed that none of patients' and tumors' characteristics significantly impacted on complete TME.
CONCLUSIONS: Our results underline that the robotic approach to rectal resection is the better way to obtain a complete TME. However, it is mandatory that randomized clinical trials should be performed to assess definitively if robotic minimally invasive surgery is better than a laparoscopic resection.

Entities:  

Keywords:  Laparoscopic surgery; Robotic surgery; Total mesorectum excision

Mesh:

Year:  2019        PMID: 31056732     DOI: 10.1007/s00384-019-03307-0

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  31 in total

1.  Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis.

Authors:  S Duval; R Tweedie
Journal:  Biometrics       Date:  2000-06       Impact factor: 2.571

Review 2.  Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis.

Authors:  J A Sterne; M Egger; G D Smith
Journal:  BMJ       Date:  2001-07-14

3.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.

Authors:  Andreas Stang
Journal:  Eur J Epidemiol       Date:  2010-07-22       Impact factor: 8.082

4.  Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer.

Authors:  D G Jayne; H C Thorpe; J Copeland; P Quirke; J M Brown; P J Guillou
Journal:  Br J Surg       Date:  2010-11       Impact factor: 6.939

5.  Quality of total mesorectal excision and depth of circumferential resection margin in rectal cancer: a matched comparison of the first 20 robotic cases.

Authors:  M Barnajian; D Pettet; E Kazi; C Foppa; R Bergamaschi
Journal:  Colorectal Dis       Date:  2014-08       Impact factor: 3.788

Review 6.  Robotic versus laparoscopic total mesorectal excision for rectal cancer: a meta-analysis of eight studies.

Authors:  Binghong Xiong; Li Ma; Wei Huang; Qikang Zhao; Yong Cheng; Jingshan Liu
Journal:  J Gastrointest Surg       Date:  2014-11-14       Impact factor: 3.452

7.  Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial.

Authors:  Martijn Hgm van der Pas; Eva Haglind; Miguel A Cuesta; Alois Fürst; Antonio M Lacy; Wim Cj Hop; Hendrik Jaap Bonjer
Journal:  Lancet Oncol       Date:  2013-02-06       Impact factor: 41.316

8.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.

Authors:  Julian P T Higgins; Douglas G Altman; Peter C Gøtzsche; Peter Jüni; David Moher; Andrew D Oxman; Jelena Savovic; Kenneth F Schulz; Laura Weeks; Jonathan A C Sterne
Journal:  BMJ       Date:  2011-10-18

9.  Estimating the mean and variance from the median, range, and the size of a sample.

Authors:  Stela Pudar Hozo; Benjamin Djulbegovic; Iztok Hozo
Journal:  BMC Med Res Methodol       Date:  2005-04-20       Impact factor: 4.615

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

View more
  10 in total

Review 1.  [Evidence in minimally invasive oncological surgery of the colon and rectum].

Authors:  Carolin Kastner; Joachim Reibetanz; Christoph-Thomas Germer; Armin Wiegering
Journal:  Chirurg       Date:  2021-04       Impact factor: 0.955

Review 2.  Options for Low Rectal Cancer: Robotic Total Mesorectal Excision.

Authors:  Felipe F Quezada-Diaz; J Joshua Smith
Journal:  Clin Colon Rectal Surg       Date:  2021-09-08

Review 3.  The Role of Indocyanine Green Fluorescence in Rectal Cancer Robotic Surgery: A Narrative Review.

Authors:  Elena Belloni; Edoardo Maria Muttillo; Salomone Di Saverio; Marcello Gasparrini; Antonio Brescia; Giuseppe Nigri
Journal:  Cancers (Basel)       Date:  2022-05-13       Impact factor: 6.575

4.  The impact of robotic total mesorectal excision on survival of patients with rectal cancer-a propensity matched analysis.

Authors:  P Tejedor; F Sagias; K Flashman; Yeh Han Lee; S Naqvi; N Kandala; Jim Khan
Journal:  Int J Colorectal Dis       Date:  2019-11-11       Impact factor: 2.571

5.  Incidence and risk factors of portomesenteric venous thrombosis after colorectal surgery for cancer in the elderly population.

Authors:  Michele Manigrasso; Marco Milone; Nunzio Velotti; Sara Vertaldi; Pietro Schettino; Mario Musella; Giovanni Aprea; Nicola Gennarelli; Francesco Maione; Giovanni Sarnelli; Pietro Venetucci; Giovanni Domenico De Palma; Francesco Milone
Journal:  World J Surg Oncol       Date:  2019-11-19       Impact factor: 2.754

6.  Comparison of robotic and laparoscopic rectal cancer surgery: a meta-analysis of randomized controlled trials.

Authors:  Bo Tang; Xiong Lei; Junhua Ai; Zhixiang Huang; Jun Shi; Taiyuan Li
Journal:  World J Surg Oncol       Date:  2021-02-03       Impact factor: 2.754

Review 7.  The Role of Robotic Visceral Surgery in Patients with Adhesions: A Systematic Review and Meta-Analysis.

Authors:  Marco Milone; Michele Manigrasso; Pietro Anoldo; Anna D'Amore; Ugo Elmore; Mariano Cesare Giglio; Gianluca Rompianesi; Sara Vertaldi; Roberto Ivan Troisi; Nader K Francis; Giovanni Domenico De Palma
Journal:  J Pers Med       Date:  2022-02-18

Review 8.  Robotic versus laparoscopic left colectomy: a systematic review and meta-analysis.

Authors:  Leonardo Solaini; Antonio Bocchino; Andrea Avanzolini; Domenico Annunziata; Davide Cavaliere; Giorgio Ercolani
Journal:  Int J Colorectal Dis       Date:  2022-06-01       Impact factor: 2.796

9.  Clinical and oncological outcomes of the low ligation of the inferior mesenteric artery with robotic surgery in patients with rectal cancer following neoadjuvant chemoradiotherapy

Authors:  İsmail Gömcel; Orhan Aras
Journal:  Turk J Med Sci       Date:  2021-02-26       Impact factor: 0.973

10.  Robotic Colorectal Cancer Surgery. How to Reach Expertise? A Single Surgeon-Experience.

Authors:  Michele Manigrasso; Sara Vertaldi; Pietro Anoldo; Anna D'Amore; Alessandra Marello; Carmen Sorrentino; Alessia Chini; Salvatore Aprea; Salvatore D'Angelo; Nicola D'Alesio; Mario Musella; Antonio Vitiello; Giovanni Domenico De Palma; Marco Milone
Journal:  J Pers Med       Date:  2021-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.